Adenoma, Islet Cell
Adenoma, Islet Cell
Explore linked clinical trials. Standard reference: MESH:M001174446 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Diagnosing and Treating Low Blood Sugar Levels | Adenoma, Islet Cell, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Nutritional and Metabolic Diseases, adenoma, endocrine system disorder, epithelial neoplasm, glucose metabolism disease, hypoglycemia, malignant endocrine neoplasm, metabolic disease, neoplasm, pancreas disorder, pancreatic insulinoma, pancreatic neoplasm | Recruiting | Not stated | 2026-10-08 | NCT00001276 | |
| Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015) | Abnormalities, Multiple, Adenoma, Islet Cell, Ciliopathies, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, adenoma, angiomatosis, cardiovascular disorder, endocrine system disorder, epithelial neoplasm, hereditary disease, malignant endocrine neoplasm, neoplasm, nervous system disorder, neurocutaneous syndrome, neuroendocrine neoplasm, pancreas disorder, pancreatic neoplasm, pancreatic neuroendocrine tumor, paraganglioma, pheochromocytoma, pheochromocytoma-paraganglioma, primitive neuroectodermal tumor, vascular disorder, von Hippel-Lindau disease | Recruiting | Phase 2 | 2026-10-06 | NCT04924075 | |
| Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy | Adenoma, Islet Cell, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, adenocarcinoma, adenoma, carcinoid tumor, carcinoma, digestive system neuroendocrine neoplasm, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, neuroendocrine neoplasm, pancreas disorder, pancreatic neoplasm, pancreatic neuroendocrine tumor, primitive neuroectodermal tumor | Active, not recruiting | Phase 3 | 2026-10-05 | NCT05477576 | |
| Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors | Adenoma, Islet Cell, Digestive System Diseases, Digestive System Neoplasms, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, adenoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, neuroendocrine neoplasm, pancreas disorder, pancreatic neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 2 / Phase 3 | 2026-09-29 | NCT06943755 | |
| A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism | Adenoma, Islet Cell, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Adipose Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Fibrous Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Nutritional and Metabolic Diseases, adenoma, connective tissue neoplasm, endocrine system disorder, epithelial neoplasm, fibrosarcoma, glucose metabolism disease, hyperinsulinism, hypoglycemia, liposarcoma, malignant endocrine neoplasm, metabolic disease, neoplasm, neuroendocrine neoplasm, neuroepithelial neoplasm, pancreas disorder, pancreatic insulinoma, pancreatic neoplasm, primitive neuroectodermal tumor, sarcoma | Recruiting | Phase 3 | 2026-09-28 | NCT06881992 | |
| Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors | Adenoma, Islet Cell, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, adenoma, endocrine system disorder, epithelial neoplasm, functional pancreatic neuroendocrine tumor, lung neuroendocrine neoplasm, malignant endocrine neoplasm, neoplasm, neuroendocrine neoplasm, non-functional pancreatic neuroendocrine tumor, pancreas disorder, pancreatic neoplasm, primitive neuroectodermal tumor, thymic neuroendocrine tumor | Active, not recruiting | Phase 3 | 2026-09-22 | NCT03375320 | |
| Optimizing Risk Assessment Through cfDNA in Pancreatic Neuroendocrine Tumors for Clinical Evaluation | Adenoma, Islet Cell, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, pancreatic neuroendocrine tumor | Active, not recruiting | Not stated | 2026-09-16 | NCT07817225 | |
| Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs. | Adenoma, Islet Cell, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, adenocarcinoma, adenoma, carcinoid tumor, carcinoma, digestive system neuroendocrine neoplasm, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, neuroendocrine neoplasm, pancreas disorder, pancreatic neoplasm, pancreatic neuroendocrine tumor, primitive neuroectodermal tumor | Recruiting | Phase 1 | 2026-09-15 | NCT07165132 | |
| Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors | Adenoma, Islet Cell, DNA Virus Infections, Digestive System Diseases, Digestive System Neoplasms, Head and Neck Neoplasms, Infections, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, Thoracic Neoplasms, Tumor Virus Infections, adenocarcinoma, adenoma, appendix adenocarcinoma, carcinoma, cutaneous neuroendocrine carcinoma, cystic, mucinous, and serous neoplasm, endocrine system disorder, epithelial neoplasm, lung disorder, lung neoplasm, malignant endocrine neoplasm, malignant mesothelioma, mesothelial neoplasm, mesothelioma, mucinous adenocarcinoma, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, otorhinolaryngologic disease, pancreas disorder, pancreatic neoplasm, pancreatic neuroendocrine tumor, pleural neoplasm, polyomavirus infectious disease, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract neoplasm, viral infectious disease | Active, not recruiting | Phase 2 | 2026-09-14 | NCT03074513 | |
| Comparison of [68Ga]Ga-HBED-CC-PEG6-Exendin-4 and [68Ga]Ga-HBED-CC-Exendin-4 PET/CT for Insulinoma Localization | Adenoma, Islet Cell, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic insulinoma, pancreatic neoplasm | Recruiting | Not applicable | 2026-09-09 | NCT07808879 | |
| Precision Radiotherapy Using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 Patients | Adenoma, Islet Cell, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Multiple Primary, adenoma, endocrine system disorder, epithelial neoplasm, hereditary disease, hereditary neoplastic syndrome, malignant endocrine neoplasm, multiple endocrine neoplasia, multiple endocrine neoplasia type 1, neoplasm, pancreas disorder, pancreatic neoplasm | Active, not recruiting | Not applicable | 2026-09-09 | NCT05037461 | |
| Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease | Adenoma, Islet Cell, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic insulinoma, pancreatic neoplasm | Recruiting | Not stated | 2026-09-08 | NCT06725693 | |
| Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors | Adenoma, Islet Cell, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Phase 1 | 2026-09-03 | NCT05687123 | |
| Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors, the ComPareNET Trial | Adenoma, Islet Cell, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Active, not recruiting | Phase 2 | 2026-09-02 | NCT05247905 | |
| Endoscopic Ultrasound-Guided Pulsed Electric Field Ablation for the Treatment of Pancreatic Neoplasms | Adenoma, Islet Cell, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, pancreatic neuroendocrine tumor | Not yet recruiting | Not applicable | 2026-06-02 | NCT07619417 | |
| Multicenter Trial of ESK981 in Patients With Select Solid Tumors | Adenoma, Islet Cell, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, adenocarcinoma, adenoma, adenosquamous carcinoma, carcinoma, digestive system neuroendocrine neoplasm, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, mixed neoplasm, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, pancreas disorder, pancreatic adenocarcinoma, pancreatic endocrine carcinoma, pancreatic neoplasm, pancreatic neuroendocrine tumor, primitive neuroectodermal tumor, somatostatinoma | Active, not recruiting | Phase 2 | 2026-05-14 | NCT05988918 | |
| Safety and Efficacy of EUS-RFA in Pancreatic Insulinoma | Adenoma, Islet Cell, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic insulinoma, pancreatic neoplasm | Recruiting | Not stated | 2026-05-13 | NCT07585032 | |
| DOTATOC PET/CT for Imaging NET Patients | Adenoma, Islet Cell, Carcinoma, Medullary, DNA Virus Infections, Digestive System Diseases, Digestive System Neoplasms, Infections, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, Pituitary Neoplasms, Thoracic Neoplasms, Tumor Virus Infections, VIPoma, adenocarcinoma, adenoma, brain disorder, bronchial neoplasm, bronchogenic carcinoma, carcinoid tumor, carcinoma, central nervous system cancer, central nervous system disorder, cutaneous neuroendocrine carcinoma, endocrine system disorder, epithelial neoplasm, glioma, glucagonoma, hypothalamic disorder, hypothalamic neoplasm, lung disorder, lung neoplasm, malignant endocrine neoplasm, medulloblastoma, meningioma, neoplasm, nervous system disorder, neuroblastoma, neuroendocrine carcinoma, neuroendocrine neoplasm, neuroepithelial neoplasm, pancreas disorder, pancreatic endocrine carcinoma, pancreatic insulinoma, pancreatic neoplasm, paraganglioma, pheochromocytoma, pituitary gland adenoma, pituitary gland disorder, polyomavirus infectious disease, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma, supratentorial cancer, tumor of meninges, vascular cancer, viral infectious disease | Active, not recruiting | Not stated | 2026-05-12 | NCT03583528 | |
| Nutrition Intervention for Pancreatic Cancer | Adenoma, Islet Cell, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenoma, endocrine system disorder, epithelial neoplasm, exocrine pancreatic insufficiency, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Not applicable | 2026-05-07 | NCT07554560 | |
| Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001) | Adenoma, Islet Cell, Carcinoma, Medullary, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, adenocarcinoma, adenoma, adrenal cortex disorder, adrenal cortex neoplasm, adrenal gland cancer, adrenal gland disorder, carcinoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, medullary thyroid gland carcinoma, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, pancreas disorder, pancreatic neoplasm, pancreatic neuroendocrine tumor, primitive neuroectodermal tumor, thymic neuroendocrine carcinoma | Recruiting | Not applicable | 2026-04-09 | NCT06141369 | |
| Plasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic Tumors | Adenoma, Islet Cell, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, pancreatic neuroendocrine tumor | Recruiting | Not stated | 2026-03-25 | NCT05847855 | |
| Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors | Adenoma, Islet Cell, Digestive System Diseases, Digestive System Neoplasms, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Uveal Neoplasms, adenocarcinoma, adenoma, adrenal cortex disorder, adrenal cortex neoplasm, adrenal gland cancer, adrenal gland disorder, breast cancer, breast disorder, breast neoplasm, carcinoma, endocrine system disorder, epithelial neoplasm, eye disorder, head and neck squamous cell carcinoma, lung adenocarcinoma, lung neoplasm, malignant endocrine neoplasm, melanocytic neoplasm, melanoma, metastatic melanoma, neoplasm, neuroendocrine neoplasm, ocular cancer, pancreas disorder, pancreatic neoplasm, pancreatic neuroendocrine tumor, paraganglioma, pheochromocytoma, primitive neuroectodermal tumor, respiratory tract neoplasm, skin disorder, skin neoplasm, squamous cell carcinoma, thyroid gland disorder, thyroid tumor, uveal disorder, uveal melanoma | Recruiting | Phase 1 | 2026-03-17 | NCT04119024 | |
| Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders | Adenoma, Islet Cell, Chronic Disease, Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute pancreatitis, adenocarcinoma, adenoma, carcinoma, chronic pancreatitis, endocrine system disorder, epithelial neoplasm, hereditary chronic pancreatitis, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, pancreas disorder, pancreatic adenocarcinoma, pancreatic endocrine carcinoma, pancreatic neoplasm, pancreatic neuroendocrine tumor, pancreatitis, primitive neuroectodermal tumor, somatostatinoma | Recruiting | Not stated | 2026-03-09 | NCT00830557 | |
| AI-Powered Precision Decision-Making for Pancreatic Diseases | Adenoma, Islet Cell, Chronic Disease, Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, Pancreatic Intraductal Neoplasms, Pancreatic Intraductal Papillary Mucinous Neoplasm, Pathologic Processes, Pathological Conditions, Signs and Symptoms, adenoma, chronic pancreatitis, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, pancreatic neuroendocrine tumor, pancreatitis | Recruiting | Not stated | 2026-02-27 | NCT07439757 | |
| Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms | Adenoma, Islet Cell, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, pancreatic neuroendocrine neoplasm | Recruiting | Not stated | 2026-01-26 | NCT05746182 |